Company intelligence / Profile preview

Eurofins Modern Genomic Services

Ownership: Private
Employees: ~9
Development stage: Other

Overview

Eurofins Modern Genomic Services is an active subsidiary of the global life sciences group Eurofins Scientific. The company offers comprehensive genomics laboratory services supporting drug discovery, precision medicine development, biomarker discovery, preclinical and clinical trials for pharmaceutical and biotechnology companies. Their offerings include next-generation sequencing (NGS), genotyping/microarrays/Sanger sequencing panels for research or diagnostics applications. They are part of a global network with advanced facilities and accreditations suitable for regulated environments in pharma/biotech R&D [3][8].

Modalities: Small moleculeBiologicmRNA-based drugsAntibodyCell therapy
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Eurofins Modern Genomic Services.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eurofins Modern Genomic Services.

Explore the full profile